Although PTEN loss was initially evaluated through genomic approaches, subsequent studies have shifted toward IHC as the correlation between the two is high, and some tumours presenting PTEN inactivation do not show genomic loss [84,88,89]. This evidence concerns the gene PTEN and neoplasm.